Ipsen S.A. (EPA:IPN)
France · Delayed Price · Currency is EUR 143.20
-0.30 (-0.21%)
Sep 29, 2026, 5:35 PM CET
Ipsen Market Cap
Ipsen has a market cap or net worth of €11.74 billion as of September 29, 2026. Its market cap has increased by 27.81% in one year.
Market Cap
11.74B
Enterprise Value
10.73B
Revenue
4.29B
Ranking
n/a
PE Ratio
23.21
Stock Price
€143.20
ChartMarket Cap Chart
Since December 7, 2005, Ipsen's market cap has increased from 1.78B to 11.74B, an increase of 561.09%. That is a compound annual growth rate of 9.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 11.74B | 20.18% |
| Dec 31, 2025 | 9.77B | 6.72% |
| Dec 31, 2024 | 9.15B | 2.72% |
| Dec 29, 2023 | 8.91B | 7.65% |
| Dec 30, 2022 | 8.28B | 25.05% |
| Dec 31, 2021 | 6.62B | 18.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 86.26B |
| EssilorLuxottica Société anonyme | 67.15B |
| Sartorius Stedim Biotech | 21.07B |
| Eurofins Scientific SE | 13.67B |
| bioMérieux | 9.38B |
| ABIVAX Société Anonyme | 7.31B |
| Virbac | 2.58B |
| emeis Société anonyme | 1.77B |